Accused of aggressively marketing Botox to medical professionals to encourage off-label use, pharmaceutical giant Allergan will pay $600 million to settle civil and criminal accusations that it illegally marketed Botox for uses for which the drug had not been approved, according to the U.S. Attorney's Office for the Northern District of Georgia.
Allergan to pay $600M for illegally marketing Botox
Sep 2, 2010
Latest in Whitening
Where dental patients feel most sensitive during whitening
October 21, 2024
N.H. tops list of U.S. states for stained smiles
July 12, 2023